Boditech Med Inc. (206640.KQ)

KRW 17340.0

(0.29%)

Total Assets Summary of Boditech Med Inc.

Boditech Med Inc.'s latest annual total assets in 2023 was 227.9 Billion KRW , up 16.48% from previous year.
Boditech Med Inc.'s latest quarterly total assets in 2024 Q2 was 249.77 Billion KRW , up 8.09% from previous quarter.
Boditech Med Inc. reported annual total assets of 195.65 Billion KRW in 2022, up 1.78% from previous year.
Boditech Med Inc. reported annual total assets of 192.24 Billion KRW in 2021, up 17.6% from previous year.
Boditech Med Inc. reported quarterly total assets of 249.77 Billion KRW for 2024 Q2, up 8.09% from previous quarter.
Boditech Med Inc. reported quarterly total assets of 205.66 Billion KRW for 2023 Q2, up 0.87% from previous quarter.

Annual Total Assets Chart of Boditech Med Inc. (2023 - 2015)

Historical Annual Total Assets of Boditech Med Inc. (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	227.9 Billion KRW	16.48%
2022	195.65 Billion KRW	1.78%
2021	192.24 Billion KRW	17.6%
2020	163.47 Billion KRW	61.44%
2019	101.26 Billion KRW	-2.11%
2018	103.44 Billion KRW	-5.9%
2017	109.92 Billion KRW	21.08%
2016	90.79 Billion KRW	25.14%
2015	72.55 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	231.08 Billion KRW	1.4%
2024 Q2	249.77 Billion KRW	8.09%
2023 Q2	205.66 Billion KRW	0.87%
2023 Q4	227.9 Billion KRW	4.62%
2023 FY	227.9 Billion KRW	16.48%
2023 Q3	217.83 Billion KRW	5.92%
2023 Q1	203.89 Billion KRW	4.21%
2022 Q1	194.32 Billion KRW	1.09%
2022 Q3	199.42 Billion KRW	4.49%
2022 Q2	190.85 Billion KRW	-1.79%
2022 Q4	195.65 Billion KRW	-1.89%
2022 FY	195.65 Billion KRW	1.78%
2021 FY	192.24 Billion KRW	17.6%
2021 Q1	169.64 Billion KRW	3.77%
2021 Q2	173.97 Billion KRW	2.56%
2021 Q3	193.76 Billion KRW	11.37%
2021 Q4	192.24 Billion KRW	-0.78%
2020 Q2	118.32 Billion KRW	12.21%
2020 Q4	163.47 Billion KRW	18.13%
2020 Q3	138.38 Billion KRW	16.95%
2020 Q1	105.45 Billion KRW	4.14%
2020 FY	163.47 Billion KRW	61.44%
2019 Q2	102.17 Billion KRW	-1.39%
2019 FY	101.26 Billion KRW	-2.11%
2019 Q4	101.26 Billion KRW	2.79%
2019 Q3	98.51 Billion KRW	-3.58%
2019 Q1	103.61 Billion KRW	0.17%
2018 Q2	109.6 Billion KRW	0.73%
2018 FY	103.44 Billion KRW	-5.9%
2018 Q4	103.44 Billion KRW	-5.01%
2018 Q1	108.8 Billion KRW	0.59%
2018 Q3	108.89 Billion KRW	-0.65%
2017 FY	109.92 Billion KRW	21.08%
2017 Q1	97.7 Billion KRW	7.61%
2017 Q2	118.68 Billion KRW	21.47%
2017 Q3	118.54 Billion KRW	-0.11%
2017 Q4	108.16 Billion KRW	-8.76%
2016 Q3	88.67 Billion KRW	6.58%
2016 Q1	80.44 Billion KRW	12.18%
2016 Q2	83.19 Billion KRW	3.42%
2016 FY	90.79 Billion KRW	25.14%
2016 Q4	90.79 Billion KRW	2.39%
2015 Q3	68.72 Billion KRW	0.0%
2015 FY	72.55 Billion KRW	0.0%
2015 Q4	71.7 Billion KRW	4.34%

Peer Total Assets Comparison of Boditech Med Inc.

Name	Total Assets	Total Assets Difference
HLB Pharmaceutical Co., Ltd	141.35 Billion KRW	-61.23%
CMG Pharmaceutical Co., Ltd.	186.85 Billion KRW	-21.969%
Celltrion Pharm, Inc.	641.64 Billion KRW	64.482%
Huons Global Co., Ltd.	1317.96 Billion KRW	82.708%
DongKook Pharmaceutical Co., Ltd.	839.53 Billion KRW	72.854%
Enzychem Lifesciences Corporation	211.54 Billion KRW	-7.732%
Humedix Co., Ltd.	219.97 Billion KRW	-3.602%
EuBiologics Co., Ltd.	172.64 Billion KRW	-32.008%
FutureChem Co.,Ltd	72.83 Billion KRW	-212.909%
Huons Co., Ltd.	537.28 Billion KRW	57.583%
BNC Korea Co., Ltd.	236.15 Billion KRW	3.494%
AptaBio Therapeutics Inc.	92.51 Billion KRW	-146.329%